CDKN2B-AS1 and neoplasm: Expression of ANRIL causes an epigenetic repression of the INK locus where the p15 and p16 CDK inhibitors are located and ANRIL is critical for cell-cycle regulation and tumor progression (Kotake et al. 2011; Yap et al. 2010).